1. Surveillance, Epidemiology, and End Results (SEER) Program. (
www.seer.cancer.gov
.) SEER*Stat Database: Mortality—All COD, Public-Use With State, Total US (1969–2003), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2006. Underlying mortality data provided by NCHS (
www.cdc.gov/nchs
.).
2. The US Preventive Services Task Force (USPSTF). Recommendations and Rationale for Screening for Prostate Cancer. The US Department of Health and Human Services: Washington (DC). Available at:
http://www.ahrq.gov/clinic/3rduspstf/prostatescr/prostaterr.htm
.
3. de Koning HJ, Auvinen A, Berenguer Sanchez A, Calais da Silva F, Ciatto S, Denis L et al. Large-scale randomized prostate cancer screening trials: program performances in the European Randomized Screening for Prostate Cancer Trial and the Prostate, Lung, Colorectal and Ovary Cancer Trial. Int J Cancer 2002; 97: 237–244.
4. Prorok PC, Andriole GL, Bresalier RS, Buys SS, Chia D, Crawford ED et al. Design of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials 2000; 21 (6 Suppl): 273S–309S.
5. Grant WB, Garland CF . The association of solar ultraviolet B (UVB) with reducing risk of cancer: multifactorial ecologic analysis of geographic variation in age-adjusted cancer mortality rates. Anticancer Res 2006; 26 (4A): 2687–2699.